ArticleScience translational medicine2024

Monoclonal antibodies that block Roundabout 1 and 2 signaling target pathological ocular neovascularization through myeloid cells.

Luiz Henrique Geraldo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.